Who are in the management team of PTC Therapeutics, Inc.?

Jun 22 2025 10:33 PM IST
share
Share Via
As of March 2022, the management team of PTC Therapeutics, Inc. includes CEO Dr. Stuart Peltz and Independent Chairman Mr. Michael Schmertzler, along with several independent directors: Dr. Allan Jacobson, Ms. Stephanie Okey, Ms. Emma Reeve, Mr. David Southwell, and Dr. Glenn Steele. This team provides governance and strategic direction for the company.
As of March 2022, the management team of PTC Therapeutics, Inc. includes the following individuals:

- Mr. Michael Schmertzler, Independent Chairman of the Board
- Dr. Stuart Peltz, Chief Executive Officer and Director
- Dr. Allan Jacobson, Independent Director
- Ms. Stephanie Okey, Independent Director
- Ms. Emma Reeve, Independent Director
- Mr. David Southwell, Independent Director
- Dr. Glenn Steele, Independent Director

This team comprises a mix of executive leadership and independent directors, contributing to the governance and strategic direction of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
PTC Therapeutics Hits New 52-Week High of $69.88, Up 81.1%
Oct 31 2025 04:11 PM IST
share
Share Via
PTC Therapeutics Hits New 52-Week High of $69.26, Up 82.16%
Oct 16 2025 06:15 PM IST
share
Share Via
PTC Therapeutics, Inc. Hits New 52-Week High of $67.40
Oct 06 2025 05:31 PM IST
share
Share Via
Is PTC Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 07:47 PM IST
share
Share Via
Is PTC Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 08:49 AM IST
share
Share Via
What does PTC Therapeutics, Inc. do?
Jun 22 2025 06:44 PM IST
share
Share Via